<DOC>
	<DOC>NCT01265225</DOC>
	<brief_summary>The goal of the investigators study is to identify a prognostic marker that will evaluate the probability of recurrence in patients with stage 0-II breast cancer following surgery to remove the tumor.</brief_summary>
	<brief_title>Prognostic Value of Stem Cell Related Markers</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Ductal Carcinoma in Situ DCIS + Microinvasion stages 1 or 11 without positive lymph nodes tumor specimen with higher than grade II BRACA 1 or BRACA 2 mutation Neoadjuvant chemotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>breast cancer stages 0-II</keyword>
</DOC>